These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
725 related articles for article (PubMed ID: 16835890)
1. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
5. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function. Zolochevska O; Figueiredo ML Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490 [TBL] [Abstract][Full Text] [Related]
8. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Yu S; Wang X; Ng CF; Chen S; Chan FL Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Wang LG; Ossowski L; Ferrari AC Oncogene; 2004 Jul; 23(30):5175-84. PubMed ID: 15156193 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor functioned as a suppressor in the prostate cancer cell line PC3 in vitro and in vivo. Yu SQ; Han BM; Shao Y; Wu JT; Zhao FJ; Liu HT; Sun XW; Tang YQ; Xia SJ Chin Med J (Engl); 2009 Nov; 122(22):2779-83. PubMed ID: 19951614 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
13. Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines. Venkateswaran V; Klotz LH; Fleshner NE Cancer Res; 2002 May; 62(9):2540-5. PubMed ID: 11980647 [TBL] [Abstract][Full Text] [Related]
14. ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. Zou JX; Zhong Z; Shi XB; Tepper CG; deVere White RW; Kung HJ; Chen H Prostate; 2006 Oct; 66(14):1474-86. PubMed ID: 16921507 [TBL] [Abstract][Full Text] [Related]
15. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Gnanapragasam VJ; Robson CN; Neal DE; Leung HY Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of prostate cancer cell survival after inhibition of AR expression. Cohen MB; Rokhlin OW J Cell Biochem; 2009 Feb; 106(3):363-71. PubMed ID: 19115258 [TBL] [Abstract][Full Text] [Related]
17. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071 [TBL] [Abstract][Full Text] [Related]
18. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055 [TBL] [Abstract][Full Text] [Related]
19. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090 [TBL] [Abstract][Full Text] [Related]
20. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]